APA

San Sebastian W., Kells A. P., Bringas J., Samaranch L., Hadaczek P., Ciesielska A., Macayan M., Pivirotto P. J., Forsayeth J., Osborne S., Wright J. F., Green F., Heller G. & Bankiewicz K. S. (2014). SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATE. : Molecular therapy. Methods & clinical development.

Chicago

San Sebastian Waldy, Kells Adrian P, Bringas John, Samaranch Lluis, Hadaczek Piotr, Ciesielska Agnieszka, Macayan Michael, Pivirotto Phillip J, Forsayeth John, Osborne Sheryl, Wright J Fraser, Green Foad, Heller Gregory and Bankiewicz Krystof S. 2014. SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATE. : Molecular therapy. Methods & clinical development.

Harvard

San Sebastian W., Kells A. P., Bringas J., Samaranch L., Hadaczek P., Ciesielska A., Macayan M., Pivirotto P. J., Forsayeth J., Osborne S., Wright J. F., Green F., Heller G. and Bankiewicz K. S. (2014). SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATE. : Molecular therapy. Methods & clinical development.

MLA

San Sebastian Waldy, Kells Adrian P, Bringas John, Samaranch Lluis, Hadaczek Piotr, Ciesielska Agnieszka, Macayan Michael, Pivirotto Phillip J, Forsayeth John, Osborne Sheryl, Wright J Fraser, Green Foad, Heller Gregory and Bankiewicz Krystof S. SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATE. : Molecular therapy. Methods & clinical development. 2014.